GSK, Merck and Pfizer in Ab&B's sights as biotech files for IPO
3 days ago · China is yet to approve a RSV vaccine, unlike the U.S. which has given the green light to shots from GSK, Moderna and Pfizer, but multiple candidates have reached the clinic ahead of Ab&B.
Pfizer Announces Closing of Joint Venture With GlaxoSmithKline …
Aug 1, 2019 · Pfizer Inc. (NYSE: PFE) today announced the closing of its joint venture with GlaxoSmithKline plc (NYSE: GSK) to combine the parties’ respective consumer healthcare businesses to create the world’s largest over-the-counter (OTC) business with …
GSK, Pfizer RSV Shots Required to Carry Guillain-Barré Syndrome ...
Jan 8, 2025 · A post-marketing review by the FDA detected an increased risk of the autoimmune condition in patients inoculated with GSK’s Arexvy and Pfizer’s Abrysvo, prompting the regulator to require adjustments to the vaccines’ labels.
GSK on top in RSV jab rollout, but is Pfizer closing the gap?
2 days ago · GSK and Pfizer’s full-year financial results show that the former is currently winning the battle for take-up of their rival respiratory syncytial virus (RSV) vaccines, although, there are...
Pfizer to exit GSK consumer health joint venture after spinoff
Jun 1, 2022 · Pfizer plans to sell its shares in a consumer health joint venture with GlaxoSmithKline after the business is spun off into a new standalone corporation called Haleon. GSK will put at least 80% of its 68% holding in the joint venture into Haleon, which is set to begin trading on the London Stock Exchange on July 18.
GSK and Pfizer's RSV vaccines to carry warnings of neurological ...
Jan 7, 2025 · GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing a rare neurological disorder, the U.S. Food Drug Administration...
Look out GSK, Pfizer and BioNTech are coming for Shingrix
3 days ago · GlaxoSmithKline places its shingles vaccine Shingrix among its top prospects, with peak sales potential of almost $6 billion. Now, Pfizer and BioNTech are joining forces to try to grab a slice...
GSK poaches Pfizer exec Dormitzer as new vaccines R&D chief
3 days ago · GlaxoSmithKline has found a replacement for head of vaccines R&D Emmanuel Hanon, who left the company for a US biotech earlier this year, hiring Phil Dormitzer from Pfizer.
Analysis-GSK, Pfizer RSV Vaccine Sales Fall in US as Millions Fewer ...
Oct 8, 2024 · (Reuters) - U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and said it was a once-in-a-lifetime shot for now, excluding...
FDA adds warning to RSV shots from GSK, Pfizer
Jan 8, 2025 · GSK’s and Pfizer’s vaccines for respiratory syncytial virus must carry labels warning of a possible increased risk of a rare neurological disorder, the Food and Drug Administration said Tuesday. The FDA has not determined a causal link between the shots and the condition, called Guillain-Barré syndrome, or GBS.